mas in Biological Technology

Nuvasive Reports Third Quarter 2008 Financial Results

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive Completes Acquisition of Osteocel Biologics Business

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive to Present at William Blair 28th Annual Growth Stock Conference

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke

...the REduction of Atherothrombosis for Continued Health (REACH) Registry: Touze E, Rother J, Alberts MJ, Goto S, Hill MD, Aichner F, Steg PG, Bhatt DL, mas JL, on behalf of the REACH Registry Investigators). Whereas the incidence rates of MI and nonstroke vascular death are only about 1% per year, the ris...

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive to Present at Canaccord Adams' Small-Cap Orthopedics Conference

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results

...l as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included i...

NuVasive to Host Investor Reception on September 11, 2007

...ll as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included in...

NuVasive to Present at Thomas Weisel Partners Healthcare Conference

...ll as a growing offering of cervical and motion preservation products. The mas platform offers advantages for both patients and surgeons such as reduced s...on cervical internal fixation products and its R&D pipeline emphasizes both mas and motion preservation. NuVasive cautions you that statements included in...

The New Affymetrix GeneChip Scanner 3000

...array and comparison analyses generated within the mas software. Analysis output files (.chp files) were ...omparisons Change calls reported in the mas software are indicators of differential gene expre...The number of Increase calls was calculated in the mas software across all 53 spiked transcripts. Average...

New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays

... (MAS) 4.0 containing the empirical algorithms and mas 5.0 containing the new statistical algorithms were...hip ® probe arrays, followed by analysis with mas 4.0 and mas 5.0. Results ...

Fine Tuning Your Data Analysis: Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms

...lt values of the tunable parameters as provided in mas 5.0. Results I....if the changes are of comparable Signal LogRatios. mas 5.0 contains a finer level of tuning for change ca...ns. The default values set for these parameters in mas 5.0 were established at Affymetrix to achieve the ...